References
- Anantharaman A, Subramanian B, Chandrasekaran R, Seenivasan R, Siva R. 2014. Colorants and cancer: a review. Ind Crops Prod. 53:167–186.10.1016/j.indcrop.2013.12.025
- Bayma JC, Arruda MS, Neto MS. 1998. A prenylated xanthone from the bark of Symphonia globulifera. Phytochemistry. 49(4):1159–1160.10.1016/S0031-9422(98)00085-5
- Ee GCL, Daud S, Taufiq-Yap YH, Ismail NH, Rahmani M. 2006. Xanthones from Garcinia mangostana (Guttiferae). Nat Prod Res. 20(12):1067–1073.10.1080/14786410500463114
- Fei X, Jo M, Lee B, Han SB, Lee K, Jung JK, Seo SY, Kwak YS. 2014. Synthesis of xanthone derivatives based on α-mangostin and their biological evaluation for anti-cancer agents. Bioorg Med Chem Lett. 24(9):2062–2065.10.1016/j.bmcl.2014.03.047
- Johnson JJ, Petiwala SM, Syed DN, Rasmussen JT, Adhami VM, Siddiqui IA, Kohl AM, Mukhtar H. 2012. α-mangostin, A xanthone from mangosteen fruit, promotes cell cycle arrest in prostate cancer and decreases Xenograft tumor growth. Carcinogenesis. 33(2):413–419.10.1093/carcin/bgr291
- Lemos LMS, Oliveira RB, Sampaio BL, Ccana-Ccapatinta GV, Da Costa FB, Martins DTO. 2016. Brasiliensic and isobrasiliensic acids: isolation from Calophyllum brasiliense Cambess. and anti-Helicobacter pylori activity. Nat Prod Res. 30(23):2720–2725. doi:10.1080/14786419.2015.1137568.
- Lim CK, Subramaniam H, Say YH, Jong VYM, Khaledi H, Chee CF. 2015. A new chromanone acid from the stem bark of Calophyllum teysmannii. Nat Prod Res. 29(21):1970–1977.10.1080/14786419.2015.1015020
- Mah SH, Ee GCL, Teh SS, Rahmani M, Lim YM, Go R. 2012. Phylattrin, a new cytotoxic xanthone from Calophyllum soulattri. Molecules. 17(12):8303–8311.10.3390/molecules17078303
- Na Y. 2009. Recent cancer drug development with xanthone structures. J Pharm Pharmacol. 61(6):707–712.10.1211/jpp.61.06.0002
- ©WHO 2017, 2017 Feb. Cancer, Fact Sheet. https://www.who.int/mediacentre/factsheets/fs297/en/.